Lepu Medical Tech Beijing (SHE:300003) — Market Cap & Net Worth
Market Cap & Net Worth: Lepu Medical Tech Beijing (300003)
Lepu Medical Tech Beijing (SHE:300003) has a market capitalization of $3.04 Billion (CN¥20.79 Billion) as of September 18, 2026. Listed on the SHE stock exchange, this China-based company holds position #4893 globally and #821 in its home market, demonstrating a -1.83% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Lepu Medical Tech Beijing's stock price CN¥11.28 by its total outstanding shares 1843424716 (1.84 Billion). Also see Lepu Medical Tech Beijing balance sheet assets for a full breakdown of the balance sheet.
Lepu Medical Tech Beijing Market Cap History: 2015 to 2026
Lepu Medical Tech Beijing's market capitalization history from 2015 to 2026. Data shows change from $4.71 Billion to $3.04 Billion (-3.32% CAGR). Also see 300003 cash generation efficiency for how efficiently the company converts equity into cash flow.
Index Memberships
Lepu Medical Tech Beijing is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
ChiNext
CNT
|
$1.15 Trillion | 0.26% | #66 of 100 |
Weight: Lepu Medical Tech Beijing's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Lepu Medical Tech Beijing Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Lepu Medical Tech Beijing's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Lepu Medical Tech Beijing stock quote for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.66x
Lepu Medical Tech Beijing's market cap is 0.66 times its annual revenue
Latest Price to Earnings (P/E) Ratio
4.43x
Lepu Medical Tech Beijing's market cap is 4.43 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $4.39 Billion | $3.47 Billion | $679.26 Million | 1.27x | 6.47x |
| 2017 | $5.95 Billion | $4.54 Billion | $899.09 Million | 1.31x | 6.62x |
| 2018 | $5.14 Billion | $6.36 Billion | $1.22 Billion | 0.81x | 4.22x |
| 2019 | $8.24 Billion | $7.80 Billion | $1.73 Billion | 1.06x | 4.77x |
| 2020 | $6.81 Billion | $8.04 Billion | $1.80 Billion | 0.85x | 3.78x |
| 2021 | $5.71 Billion | $10.66 Billion | $1.72 Billion | 0.54x | 3.32x |
| 2022 | $5.88 Billion | $10.61 Billion | $2.20 Billion | 0.55x | 2.67x |
| 2023 | $4.20 Billion | $7.98 Billion | $1.26 Billion | 0.53x | 3.34x |
| 2024 | $3.06 Billion | $6.10 Billion | $246.94 Million | 0.50x | 12.39x |
| 2025 | $4.26 Billion | $6.48 Billion | $962.01 Million | 0.66x | 4.43x |
Competitor Companies of 300003 by Market Capitalization
Companies near Lepu Medical Tech Beijing in the global market cap rankings as of September 18, 2026. Review Lepu Medical Tech Beijing tangible equity quality to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Lepu Medical Tech Beijing by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #126 globally with a market cap of $177.76 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #229 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #235 globally with a market cap of $107.45 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #241 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #126 | Abbott Laboratories | NYSE:ABT | $177.76 Billion | $102.23 |
| #229 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $92.77 |
| #235 | Stryker Corporation | NYSE:SYK | $107.45 Billion | $280.13 |
| #241 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Lepu Medical Tech Beijing Historical Marketcap From 2015 to 2026
Between 2015 and today, Lepu Medical Tech Beijing's market cap moved from $4.71 Billion to $ 3.04 Billion, with a yearly change of -3.32%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥3.04 Billion | -28.65% |
| 2025 | CN¥4.26 Billion | +39.42% |
| 2024 | CN¥3.06 Billion | -27.17% |
| 2023 | CN¥4.20 Billion | -28.59% |
| 2022 | CN¥5.88 Billion | +3.04% |
| 2021 | CN¥5.71 Billion | -16.13% |
| 2020 | CN¥6.81 Billion | -17.37% |
| 2019 | CN¥8.24 Billion | +60.14% |
| 2018 | CN¥5.14 Billion | -13.55% |
| 2017 | CN¥5.95 Billion | +35.38% |
| 2016 | CN¥4.39 Billion | -6.69% |
| 2015 | CN¥4.71 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 18th, 2026 the market cap of Lepu Medical Tech Beijing was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.04 Billion USD |
| MoneyControl | $3.04 Billion USD |
| MarketWatch | $3.04 Billion USD |
| marketcap.company | $3.04 Billion USD |
| Reuters | $3.04 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Lepu Medical Tech Beijing
Lepu Medical Technology (Beijing) Co., Ltd., together with its subsidiaries, engages in the research, development, and manufacturing of cardiac interventional medical devices in China and internationally. The company operates through three segments: Medical Devices; Pharmaceuticals; and Medical Services and Health Management. It offers medical devices, including cardiovascular devices, in vitro d… Read more